P. Tønnesen (Glostrup, Denmark), E. Dagli (Istanbul, Turkey)
Use of cytisine for smoking cessation in Italian Centers for Tobacco Treatment
R. Principe (ROMA, RM, Italy)
|   |
Influence of psychiatric disorders in patients treated with Varenicline.
N. Fouz Rosón (Barcelona, Spain)
| |
Characteristics of smokers according to their Nicotine Metabolite Ratio, preliminary results from a real-life experience
G. Puppo (Pisa, PI, Italy)
| |
Short-term low-dose vs standard-dose Varenicline therapy for smoking cessation: a randomized controlled trial.
N. Fouz Rosón (Barcelona, Spain)
| |
Pharmacological correction of connective tissue dismetabolism in aorta of rats with experimental tobacco smoking
V. Nevzorova (Vladivostok, Primorsky Krai, Russian Federation)
| |
Cytisine is an effective smoking cessation medication: more evidence now than ever before
D. Vinnikov (Bishkek, Kyrgyzstan)
| |
Medical treatment effectiveness in smoking cessation
I. Pešic (Beograd, Republic of Serbia)
| |
A bibliometric overview of e-cigarette publications from 2007 to 2016.
F. Filippidis (London, United Kingdom)
| |
Highest prevalence of respiratory symptoms among smokers who also use e-cigarettes
L. Hedman (Luleå, Sweden)
| |
Prevalence and knowledge of electronic cigarettes amongst medical students, A cross sectional survey from Karachi, Pakistan
N. Iqbal (KARACHI, Pakistan)
| |
Cigarette and e-cigarette smoking among medical and non-medical students in Poland
G. Brozek (Katowice, Poland)
| |
Symptoms reported by electronic-cigarettes users in social media
E. Dagli (Istanbul, Turkey)
| |
Analysis of an electronic cigarette social media forum
E. Dagli (Istanbul, Turkey)
| |
The impact of cigarette and e-cigarette smoking on human health.
M. Jankowski (Katowice, Poland)
| |